Diana González-Bermejo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Patient Reported Outcomes

Dendritic Cells

Prognostic Factors

Top Venues

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Monreal-Di Bello, Diana González-Bermejo, Belén Castillo-Cano, Alfonso Rodriguez-Pascual, Dolores Montero-Corominas
Impact of Regulatory Interventions on Ulipristal Acetate 5 mg (Esmya) Use in Spain: An Interrupted Time-Series Analysis. Pharmacoepidemiology and drug safety 33 (9) (2024)
Rasha Alqdwah-Fattouh, Sara Rodríguez-Martín, Diana Barreira-Hernández, Laura Izquierdo-Esteban, Miguel Gil, Diana González-Bermejo, Encarnación Fernández-Antón, Antonio Rodríguez-Miguel, Alberto García-Lledó, Francisco Bolúmar, Francisco José de Abajo
Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study. Stroke 53 (5) (2022)
Diana González-Bermejo, Belén Castillo-Cano, Alfonso Rodríguez-Pascual, Mª Félix García-Martín, Arturo Álvarez-Gutiérrez, Dolores Montero-Corominas, Consuelo Huerta-Álvarez
Effect of regulatory interventions on agomelatine use in Spain: A multiple intervention time-series analysis in a nationwide electronic healthcare record database. Pharmacoepidemiology and drug safety (2021)
Diana González-Bermejo, Pilar Rayón-Iglesias, Alfonso Rodríguez-Pascual, Arturo Álvarez-Gutiérrez, Ana Fernández-Dueñas, Dolores Montero-Corominas, Consuelo Huerta-Álvarez
Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication. Pharmacoepidemiology and drug safety 30 (3) (2020)